Target intelligence / Profile preview

Mitochondrial ribosomal protein S21 pseudogene 2 (MRPS21P2)

Target
MRPS21P2
Molecular classification
Other (Pseudogene), Not a receptor, enzyme, transporter, or transcription factor
01

Overview

MRPS21P2 (mitochondrial ribosomal protein S21 pseudogene 2) is a human pseudogene corresponding to the mitochondrial ribosomal protein S21 family[2][3][6][10]. While the functional parent gene (MRPS21) encodes a protein required for mitochondrial ribosome small subunit assembly and protein synthesis within mitochondria, MRPS21P2 does **not** produce a functional protein. Pseudogenes such as MRPS21P2 arise from gene duplication or retrotransposition events and are considered non-functional genomic elements, although some may play regulatory roles in rare cases[6][8]. There are no annotated biological functions, disease associations, drug interactions, or known biomedical relevance specifically for MRPS21P2. Key interpretation note: MRPS21P2—unlike the parent MRPS21 gene—is not a therapeutic, enzymatic, or receptor target, but rather a genetic "fossil" (pseudogene) preserved in the human genome[3][4][6][10].

Other names
MRPS21 pseudogene 2mitochondrial ribosomal protein S21 pseudogene 2
02

Mechanism of action

Not applicable. As a pseudogene, MRPS21P2 is not targeted by drug mechanisms.

03

Biological functions

Pseudogenes like MRPS21P2 generally do not encode proteins and lack direct biological function.Some pseudogenes may have regulatory roles (such as acting as decoys for microRNAs or influencing gene expression), but no such function is annotated or validated for MRPS21P2 specifically
04

Disease associations

None known. There are no disease associations established for MRPS21P2
05

Safety considerations

None reported, as this gene is not a drug target or biomarker
06

Interacting drugs

None. There are no drugs known to interact with MRPS21P2
07

Biomarkers

None. MRPS21P2 is not documented as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Mitochondrial ribosomal protein S21 pseudogene 2 (MRPS21P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein S21 pseudogene 2 (MRPS21P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call